Skip to main content Accessibility help
×
Home

The role of folic acid in fetal programming of birth phenotypes and early human development: a biopsychosocial perspective

  • H. M. Salihu (a1), A. Salinas-Miranda (a2), C. de la Cruz (a3) and A. P. Alio (a4)

Abstract

Preterm birth, low birthweight, intrauterine growth retardation and small for gestational age are birth phenotypes that significantly contribute to life-long morbidity and mortality. This review examines the epidemiologic and biologic evidence of folic acid (FA) as a potential population-based intervention to curtail some adverse birth phenotypic expressions, and by extension, their later physical and neurodevelopmental consequences. We outlined a feto-placental adaptation categorization taking into account how prenatal insults may be encoded in fetal development, the adaptive success of the feto-placental response, and subsequent expression in the health of the fetus. Although there are plausible biological pathways that can be implicated, we found that the epidemiological evidence on the role of perinatal FA nutriture and fetal programming of adverse birth phenotypes is still inconclusive. Because biologic and epidemiological considerations alone do not suffice in deciphering the utility of FA in averting adverse birth phenotypes, we proposed a biopsychosocial model that takes into account multi-layered psychosocial contexts for improving subsequent research studies in this area.

Copyright

Corresponding author

*Address for correspondence: Dr H. M. Salihu, Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, 13201 Bruce B. Downs, MDC56, Tampa, FL 33612, USA. (Email hsalihu@health.usf.edu)

References

Hide All
1.Gluckman, PD, Cutfield, W, Hofman, P, Hanson, MA. The fetal, neonatal, and infant environments-the long-term consequences for disease risk. Early Hum Dev. 2005; 81, 5159.
2.Simmons, RA. Developmental origins of adult disease. Pediatr Clin North Am. 2009; 56, 449466.
3.Yajnik, CS, Deshmukh, US. Maternal nutrition, intrauterine programming and consequential risks in the offspring. Rev Endocr Metab Disord. 2008; 9, 203211.
4.Barker, D. Fetal origins of coronary heart disease. BMJ. 1995; 311, 171174.
5.Barker, DJ. Intrauterine programming of adult disease. Mol Med Today. 1995; 1, 418423.
6.Barker, DJ. Fetal nutrition and cardiovascular disease in later life. Br Med Bull. 1997; 53, 96108.
7.Barker, DJ, Eriksson, JG, Forsen, T, Osmond, C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002; 31, 12351239.
8.Barker, DJ, Osmond, C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986; 1, 10771081.
9.Barker, DJ, Osmond, C, Golding, J, Kuh, D, Wadsworth, ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989; 298, 564567.
10.Barker, DJ, Osmond, C, Law, CM. The intrauterine and early postnatal origins of cardiovascular disease and chronic bronchitis. J Epidemiol Community Health. 1989; 43, 237240.
11.Barker, DJ. The foetal and infant origins of inequalities in health in Britain. J Public Health Med. 1991; 13, 6468.
12.Wadhwa, PD, Buss, C, Entringer, S, Swanson, JM. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med. 2009; 27, 358368.
13.Barker, DJP. Fetal nutrition and cardiovascular disease in later life. Br Med Bull. 1997; 53, 96108.
14.Dyer, JS, Rosenfeld, CR. Metabolic imprinting by prenatal, perinatal, and postnatal overnutrition: a review. Semin Reprod Med. 2011; 29, 266276.
15.Sinclair, KD, Lea, RG, Rees, WD, Young, LE. The developmental origins of health and disease: current theories and epigenetic mechanisms. Soc Reprod Fertil Suppl. 2007; 64, 425443.
16.Fowden, AL, Giussani, DA, Forhead, AJ. Intrauterine programming of physiological systems: causes and consequences. Physiology. 2006; 21, 2937.
17.Rinaudo, P, Wang, E. Fetal programming and metabolic syndrome. Ann Rev Physiol. 2012; 74, 107130.
18.Rueda-Clausen, CF, Morton, JS, Davidge, ST. The early origins of cardiovascular health and disease: who, when, and how. Semin Reprod Med. 2011; 29, 197210.
19.Ojeda, NB, Grigore, D, Alexander, BT. Role of fetal programming in the development of hypertension. Future Cardiol. 2008; 4, 163174.
20.Woods, LL. Maternal nutrition and predisposition to later kidney disease. Curr Drug Targets. 2007; 8, 906913.
21.Beydoun, H, Saftlas, AF. Physical and mental health outcomes of prenatal maternal stress in human and animal studies: a review of recent evidence. Paediatr Perinat Epidemiol. 2008; 22, 438466.
22.Ward, AM, Phillips, DI. Fetal programming of stress responses. Stress. 2001; 4, 263271.
23.Salihu, HM, Mbah, AK, Alio, AP, Kirby, RS. AGA-primed uteri compared with SGA-primed uteri and the success of subsequent in utero fetal programming. Obstet Gynecol. 2008; 111, 935943.
24.Johnson, EM, Newman, LM, Schmidt, RR. Postnatal effects of prenatal insult. Risk Anal. 1988; 8, 3544.
25.Gabory, A, Attig, L, Junien, C. Epigenetic mechanisms involved in developmental nutritional programming. World J Diabetes. 2011; 2, 164175.
26.Fowden, AL, Forhead, AJ. Endocrine mechanisms of intrauterine programming. Reproduction. 2004; 127, 515526.
27.Velez, DR, Fortunato, S, Thorsen, P, et al. Spontaneous preterm birth in African Americans is associated with infection and inflammatory response gene variants. Am J Obstet Gynecol. 2009; 200, 209e201209e227.
28.Uchide, N, Ohyama, K, Bessho, T, Toyoda, H. Induction of pro-inflammatory cytokine gene expression and apoptosis in human chorion cells of fetal membranes by influenza virus infection: possible implications for maintenance and interruption of pregnancy during infection. Med Sci Monit. 2005; 11, RA7RA16.
29.Romero, R, Chaiworapongsa, T, Espinoza, J. Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J Nutr. 2003; 133(Suppl 2), 1668S1673S.
30.Young, LE. Imprinting of genes and the Barker hypothesis. Twin Res. 2001; 4, 307317.
31.Bird, A. Perceptions of epigenetics. Nature. 2007; 447, 396398.
32.Callinan, PA, Feinberg, AP. The emerging science of epigenomics. Hum Mol Genet. 2006; 15(Spec No 1), R95R101.
33.Burdge, GC, Hanson, MA, Slater-Jefferies, JL, Lillycrop, KA. Epigenetic regulation of transcription: a mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life? Br J Nutr. 2007; 97, 10361046.
34.Crider, KS, Yang, TP, Berry, RJ, Bailey, LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Adv Nutr. 2012; 3, 2138.
35.Jacob, RA. Folate, DNA methylation, and gene expression: factors of nature and nurture. Am J Clin Nutr. 2000; 72, 903904.
36.Lewis, RM, Cleal, JK, Hanson, MA. Review: placenta, evolution and lifelong health. Placenta. 2012; 33(Suppl), S28S32.
37.Myatt, L. Placental adaptive responses and fetal programming. J Physiol. 2006; 572(Pt 1), 2530.
38.Baig, U, Belsare, P, Watve, M, Jog, M. Can thrifty gene(s) or predictive fetal programming for thriftiness lead to obesity? J Obes. 2011; 2011, 861049.
39.Wells, JC. Environmental quality, developmental plasticity and the thrifty phenotype: a review of evolutionary models. Evol Bioinform Online. 2007; 3, 109120.
40.Wells, JC. The thrifty phenotype as an adaptive maternal effect. Biol Rev Camb Philos Soc. 2007; 82, 143172.
41.Wells, JC. The thrifty phenotype: an adaptation in growth or metabolism? Am J Hum Biol. 2011; 23, 6575.
42.Fisher, RE, Steele, M, Karrow, NA. Fetal programming of the neuroendocrine-immune system and metabolic disease. J Pregnancy. 2012; 2012, 792934.
43.Geisel, J. Folic acid and neural tube defects in pregnancy: a review. J Perinat Neonatal Nurs. 2003; 17, 268279.
44.Wilson, RD, Johnson, JA, Wyatt, P, et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. JOGC. 2007; 29, 10031026.
45.Dominguez-Salas, P, Cox, SE, Prentice, AM, Hennig, BJ, Moore, SE. Maternal nutritional status, C(1) metabolism and offspring DNA methylation: a review of current evidence in human subjects. Proc Nutr Soc. 2012; 71, 154165.
46.Yajnik, CS, Deshmukh, US. Fetal programming: maternal nutrition and role of one-carbon metabolism. Rev Endocr Metab Disord. 2012; 13, 121127.
47.Hussain, N. Epigenetic influences that modulate infant growth, development, and disease. Antioxid Redox Signal. 2012; 17, 224236.
48.Green, BN, Johnson, CD, Adams, A. Writing narrative literature reviews for peer-reviewed journals: secrets of the trade. J Chiropr Med. 2006; 5, 101117.
49.Wilcox, AJ. On the importance and the unimportance of birthweight. Int J Epidemiol. 2001; 30, 12331241.
50.Goh, YI, Koren, G. Folic acid in pregnancy and fetal outcomes. J Obstet Gynaecol. 2008; 28, 313.
51.Kalhan, SC, Marczewski, SE. Methionine, homocysteine, one carbon metabolism and fetal growth. Rev Endocr Metab Disord. 2012; 13, 109119.
52.Yajnik, CS, Deshmukh, US. Maternal nutrition, intrauterine programming and consequential risks in the offspring. Rev Endocr Metab Disord. 2008; 9, 203211.
53.Sinclair, KD, Allegrucci, C, Singh, R, et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci USA. 2007; 104, 1935119356.
54.Smits, LJ, Essed, GG. Short interpregnancy intervals and unfavourable pregnancy outcome: role of folate depletion. Lancet. 2001; 358, 20742077.
55.Solanky, N, Requena Jimenez, A, D'Souza, SW, Sibley, CP, Glazier, JD. Expression of folate transporters in human placenta and implications for homocysteine metabolism. Placenta. 2010; 31, 134143.
56.Rosenquist, TH, Finnell, RH. Genes, folate and homocysteine in embryonic development. Proc Nutr Soc. 2001; 60, 5361.
57.Scholl, TO, Johnson, WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr. 2000; 71(Suppl 5), 1295S1303S.
58.Kramer, MS, Kahn, SR, Rozen, R, et al. Vasculopathic and thrombophilic risk factors for spontaneous preterm birth. Int J Epidemiol. 2009; 38, 715723.
59.Murphy, MM, Fernandez-Ballart, JD. Homocysteine in pregnancy. Adv Clin Chem. 2011; 53, 105137.
60.Burdge, GC, Lillycrop, KA. Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease. Ann Rev Nutr. 2010, 315339.
61.Dean, W, Lucifero, D, Santos, F. DNA methylation in mammalian development and disease. Birth Defects Res C Embryo Today. 2005; 75, 98111.
62.Yin, LJ, Zhang, Y, Lv, PP, et al. Insufficient maintenance DNA methylation is associated with abnormal embryonic development. BMC Med. 2012; 10, 26.
63.Jansson, T, Powell, TL. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond). 2007; 113, 113.
64.Simhan, HN, Himes, KP, Venkataramanan, R, Bodnar, LM. Maternal serum folate species in early pregnancy and lower genital tract inflammatory milieu. Am J Obstet Gynecol. 2011; 205, 61.e161.e7.
65.Courtemanche, C, Elson-Schwab, I, Mashiyama, ST, Kerry, N, Ames, BN. Folate deficiency inhibits the proliferation of primary human CD8+ T lymphocytes in vitro. J Immunol. 2004; 173, 31863192.
66.Dhur, A, Galan, P, Hercberg, S. Folate status and the immune system. Prog Food Nutr Sci. 1991; 15, 4360.
67.Hill, AB. The environment and disease: association or causation? Proc R Soc Med. 1965; 58, 295300.
68.American College of Cardiology Foundation and American Heart Association. Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines, 2011. Washington, D.C.: American College of Cardiology Foundation and American Heart Association Inc.
69.Rumbold, A, Middleton, P, Pan, N, Crowther, CA. Vitamin supplementation for preventing miscarriage. Cochrane Database of Systematic Reviews. 2011. doi: Cd004073. 10.1002/14651858.CD004073.pub3(1).
70.Mahomed, K. Folate supplementation in pregnancy (Withdrawn Paper. 2005, art no. CD00183). Cochrane Database of Systematic Reviews. 2007; July 18(3).
71.Imdad, A, Yakoob, MY, Bhutta, ZA. The effect of folic acid, protein energy and multiple micronutrient supplements in pregnancy on stillbirths. BMC Public Health. 2011; 11(Suppl 3), S4.
72.Ramakrishnan, U, Manjrekar, R, Rivera, J, Gonzales-Cossio, T, Martorell, R. Micronutrients and pregnancy outcome: a review of the literature. Nutr Res. 1999; 19, 103159.
73.Charles, DHM, Ness, AR, Campbell, D, et al. Folic acid supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane review. Paediatr Perinat Epidemiol. 2005; 19, 112124.
74.Mathews, F, Yudkin, P, Neil, A. Influence of maternal nutrition on outcome of pregnancy: prospective cohort study. BMJ. 1999; 319, 339343.
75.Nilsen, RM, Vollset, SE, Monsen, ALB, et al. Infant birth size is not associated with maternal intake and status of folate during the second trimester in Norwegian pregnant women. J Nutr. 2010; 140, 572579.
76.Stefanidis, K, Stefos, T, Vekris, A, et al. Folate status during labor: relationship with pregnancy outcomes. J Matern Fetal Med. 1999; 8, 6163.
77.Timmermans, S, Jaddoe, VWV, Hofman, A, Steegers-Theunissen, RPM, Steegers, EAP. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study. Br J Nutr. 2009; 102, 777785.
78.Goldenberg, RL, Tamura, T, Cliver, SP, et al. Serum folate and fetal growth retardation: a matter of compliance? Obstet Gynecol. 1992; 79(Pt 1), 719722.
79.Tamura, T, Goldenberg, RL, Freeberg, LE, et al. Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome. Am J Clin Nutr. 1992; 56, 365370.
80.Van Dijk, AE, Van Eijsden, M, Stronks, K, Gemke, R, Vrijkotte, TGM. Maternal depressive symptoms, serum folate status, and pregnancy outcome: results of the Amsterdam born children and their development study. Am J Obstet Gynecol. 2010; 203, 563.e1563.e7.
81.Takimoto, H, Hayashi, F, Kusama, K, et al. Elevated maternal serum folate in the third trimester and reduced fetal growth: a longitudinal study. J Nutr Sci Vitaminol. 2011; 57, 130137.
82.Sram, RJ, Binkova, B, Lnenickova, Z, Solansky, I, Dejmek, J. The impact of plasma folate levels of mothers and newborns on intrauterine growth retardation and birth weight. Mutat Res. 2005; 591, 302310.
83.Gomes, TS, Lindner, U, Tennekoon, KH, et al. Homocysteine in small-for-gestational age and appropriate-for-gestational age preterm neonates from mothers receiving folic acid supplementation. Clin Chem Lab Med. 2010; 48, 11571161.
84.Shaw, GM, Carmichael, SL, Yang, W, Siega-Riz, AM, Study, NBDP. Periconceptional intake of folic acid and food folate and risks of preterm delivery. Am J Perinatol. 2011, 28, 747752.
85.Siega-Riz, AM, Savitz, DA, Zeisel, SH, Thorp, JM, Herring, A. Second trimester folate status and preterm birth. Am J Obstet Gynecol. 2004; 191, 18511857.
86.Bukowski, R, Malone, FD, Porter, FT, et al. Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS Med. 2009; 6, e1000061.
87.Pastor-Valero, M, Navarrete-Munoz, EM, Rebagliato, M, et al. Periconceptional folic acid supplementation and anthropometric measures at birth in a cohort of pregnant women in Valencia, Spain. Br J Nutr. 2011; 105, 13521360.
88.van Eijsden, M, Smits, LJM, van der Wal, MF, Bonsel, GJ. Association between short interpregnancy intervals and term birth weight: the role of folate depletion. Am J Clin Nutr. 2008; 88, 147153.
89.Gindler, J, Li, Z, Berry, RJ, et al. Folic acid supplements during pregnancy and risk of miscarriage. Lancet. 2001; 358, 796800.
90.Bhutta, ZA, Lassi, ZS, Blanc, A, Donnay, F. Linkages among reproductive health, maternal health, and perinatal outcomes. Semin Perinatol. 2010; 34, 434445.
91.St-Laurent, J, De Wals, P, Moutquin, JM, et al. Biopsychosocial determinants of pregnancy length and fetal growth. Pediatr Perinat Epidemiol. 2008; 22, 240248.
92.Engel, GL. The need for a new medical model: a challenge for biomedicine. Science. 1977; 196, 129136.
93.Stineman, MG, Streim, JE. The biopsycho-ecological paradigm: a foundational theory for medicine. PM R. 2010; 2, 10351045.
94.Baraka, MA, Steurbaut, S, Leemans, L, et al. Determinants of folic acid use in a multi-ethnic population of pregnant women: a cross-sectional study. J Perinat Med. 2011; 39, 685692.
95.Canfield, MA, Przybyla, SM, Case, AP, et al. Folic acid awareness and supplementation among Texas women of childbearing age. Prev Med. 2006; 43, 2730.
96.Goldberg, BB, Alvarado, S, Chavez, C, et al. Prevalence of periconceptional folic acid use and perceived barriers to the postgestation continuance of supplemental folic acid: survey results from a Teratogen Information Service. Birth Defects Res A. 2006; 76, 193199.
97.de Jong-van den Berg, LTW, Hernandez-Diaz, S, Werler, MM, Louik, C, Mitchell, AA. Trends and predictors of folic acid awareness and periconceptional use in pregnant women. Am J Obstet Gynecol. 2005; 192, 121128.
98.Forster, DA, Wills, G, Denning, A, Bolger, M. The use of folic acid and other vitamins before and during pregnancy in a group of women in Melbourne, Australia. Midwifery. 2009; 25, 134146.
99.McGuire, M, Cleary, B, Sahm, L, Murphy, DJ. Prevalence and predictors of periconceptional folic acid uptake-prospective cohort study in an Irish urban obstetric population. Hum Reprod. 2010; 25, 535543.
100.Imhoff-Kunsch, B, Flores, R, Dary, O, Martorell, R. Wheat flour fortification is unlikely to benefit the neediest in Guatemala. J Nutr. 2007; 137, 10171022.
101.Oakley, GP Jr, Tulchinsky, TH. Folic acid and vitamin B12 fortification of flour: a global basic food security requirement. Public Health Rev. 2010; 32, 284295.
102.van Eijsden, M, van der Wal, MF, Bonsel, GJ. Folic acid knowledge and use in a multi-ethnic pregnancy cohort: the role of language proficiency. Bjog-Int J Obstet Gy. 2006; 113, 14461451.
103.Ray, JG, Singh, G, Burrows, RF. Evidence for suboptimal use of periconceptional folic acid supplements globally. Bjog-Int J Obstet Gy. 2004; 111, 399408.
104.Nilsen, RM, Vollset, SE, Gjessing, HK, et al. Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian mother and child cohort study. Am J Clin Nutr. 2006; 84, 11341141.
105.Paulik, E, Csaszar, J, Kozinszky, Z, Nagymajtenyi, L. Preconceptional and prenatal predictors of folic acid intake in Hungarian pregnant women. Eur J Obstet Gynecol Reprod Biol. 2009; 145, 4952.
106.Yang, QH, Carter, HK, Mulinare, J, et al. Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001–2002. Am J Clin Nutr. 2007; 85, 14091416.
107.Burguet, A, Kaminski, M, Abraham-Lerat, L, et al. The complex relationship between smoking in pregnancy and very preterm delivery. Results of the epipage study. Bjog-Int J Obstet Gy. 2004; 111, 258265.
108.Jauniaux, E, Burton, GJ. Morphological and biological effects of maternal exposure to tobacco smoke on the feto-placental unit. Early Hum Dev. 2007; 83, 699706.
109.Salihu, HM, Aliyu, MH, Pierre-Louis, BJ, Alexander, GR. Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States. Matern Child Health J. 2003; 7, 219227.
110.Mannino, DM, Mulinare, J, Ford, ES, Schwartz, J. Tobacco smoke exposure and decreased serum and red blood cell folate levels: data from the Third National Health and Nutrition Examination Survey. Nicotine Tob Res. 2003; 5, 357362.
111.Ashford, KB, Hahn, E, Hall, L, et al. The effects of prenatal secondhand smoke exposure on preterm birth and neonatal outcomes. J Obstet Gynecol Neonatal Nurs. 2010; 39, 525535.
112.Alio, AP, Salihu, HM, Kornosky, JL, Richman, AM, Marty, PJ. Feto-infant health and survival: does paternal involvement matter? Matern Child Health J. 2010; 14, 931937.
113.Suarez, L, Felkner, M, Brender, J, Canfield, M, Hendricks, K. Maternal exposures to cigarette smoke, alcohol, and street drugs and neural tube defect occurrence in offspring. Matern Child Health J. 2008; 12, 394401.
114.Morris, MS, Fava, M, Jacques, PF, Selhub, J, Rosenberg, IH. Depression and folate status in the US Population. Psychother Psychosom. 2003; 72, 8087.
115.Young, SN. Folate and depression: a neglected problem. J Psychiatry Neurosci. 2007; 32, 8082.
116.Coppen, A, Bolander-Gouaille, C. Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol. 2005; 19, 5965.
117.Papakostas, GI, Cassiello, CF, Iovieno, N. Folates and S-adenosylmethionine for major depressive disorder. Can J Psychiatry. 2012; 57, 406413.
118.Bottiglieri, T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr Rev. 1996; 54, 382390.
119.Farah, A. The role of L-methylfolate in depressive disorders. CNS Spectr. 2009; 14(Suppl 2), 27.
120.Abou-Saleh, MT, Coppen, A. Folic acid and the treatment of depression. J Psychosom Res. 2006; 61, 285287.
121.McDonnell, R, Johnson, Z, Doyle, A, Sayers, G. Determinants of folic acid knowledge and use among antenatal women. J Public Health Med. 1999; 21, 145149.
122.Salihu, HM, Ghaji, N, Mbah, AK, et al. Particulate pollutants and racial/ethnic disparity in feto-infant morbidity outcomes. Matern Child Health J. 2011. 16, 16791687.
123.Dolinoy, DC, Huang, D, Jirtle, RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA. 2007; 104, 1305613061.
124.Singh, S, Li, SS. Epigenetic effects of environmental chemicals bisphenol a and phthalates. Int J Mol Sci. 2012; 13, 1014310153.
125.Sullivan, FM. Impact of the environment on reproduction from conception to parturition. Environ Health Perspect. 1993; 101(Suppl 2), 1318.
126.Sever, LE. Looking for causes of neural tube defects: where does the environment fit in? Environ Health Perspect. 1995; 103(Suppl 6), 165171.

Keywords

The role of folic acid in fetal programming of birth phenotypes and early human development: a biopsychosocial perspective

  • H. M. Salihu (a1), A. Salinas-Miranda (a2), C. de la Cruz (a3) and A. P. Alio (a4)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed